Patents by Inventor John Gourley

John Gourley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11707508
    Abstract: The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: July 25, 2023
    Assignee: ARES TRADING S.A.
    Inventors: Alena Zalutskaya, John Gourley, Nicolas Chomont, Jean-Pierre Routy, Steven Deeks
  • Publication number: 20200061159
    Abstract: The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.
    Type: Application
    Filed: November 11, 2019
    Publication date: February 27, 2020
    Inventors: ALENA ZALUTSKAYA, JOHN GOURLEY, NICOLAS CHOMONT, JEAN-PIERRE ROUTY, STEVEN DEEKS
  • Publication number: 20180193425
    Abstract: The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.
    Type: Application
    Filed: January 11, 2018
    Publication date: July 12, 2018
    Inventors: ALENA ZALUTSKAYA, JOHN GOURLEY, NICOLAS CHOMONT, JEAN-PIERRE ROUTY, STEVEN DEEKS
  • Publication number: 20070181201
    Abstract: A cementitious pipe as a tubular wall of fibre-reinforced cementitious pseudo strain hardening (PSH) matrix. The matrix and a wall thickness to diameter ratio within a range are such that the pipe exhibits characteristic behaviour in diametral quasi-static bending under a 3-edge bearing method. The behaviour is such that a stress versus relative displacement curve for the pipe exhibits a substantially linear elastic region having a first slope within first limits, and from the LOP to the MOR for the pipe, a PSH region which, beyond a possible transition region, has a slope which is less than that of the elastic region and is within second limits.
    Type: Application
    Filed: November 19, 2004
    Publication date: August 9, 2007
    Applicant: ROCLA PTY LTD
    Inventors: Stephen Baker, John Gourley, Henrik Stang
  • Publication number: 20050005823
    Abstract: The invention relates to a particular additive and method for dispersing an admixture in a cementitious composition comprising a hydraulic cement, to provide activation of the admixture on mixing of the cementitious composition with water wherein the particles of the particulate additive comprise a carrier comprising pozzolanic material and an admixture bound to the particulate carrier wherein the particles of the additive have a median particle size of between one tenth and one half of the median particle size of the cement used in the cementitious composition.
    Type: Application
    Filed: May 25, 2004
    Publication date: January 13, 2005
    Inventors: John Gourley, Christopher Busck, Paul McCormick, Nathan Chapman, Gregory Johnson